As a senior research advisor at the Eli Lilly and Co. Biotechnology Center in San Diego, Stephen Demarest delivers innovative and novel therapeutics to treat challenging diseases such as cancer and autoimmunity. The Biotechnology Center, located in the epicenter of research, makes these innovations possible and attracts top “talent that are here for the right reasons.” “We’re in a new era of medicine that allows for both genetic and molecular hypotheses to help drive the types of biopharmaceuticals that we can make to help patients,” says Stephen. According to Donmienne Leung, a principle research scientist at Lilly, the Biotechnology Center encourages collaboration across scientific disciplines and fosters a sense of community.